(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers...
Stats | |
---|---|
Dagens volum | 19 946.00 |
Gjennomsnittsvolum | 55 784.00 |
Markedsverdi | 22.51M |
EPS | $0 ( 2024-03-27 ) |
Neste inntjeningsdato | ( $-0.390 ) 2024-05-08 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.940 |
ATR14 | $0.0230 (1.63%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Minai-azary Jennifer Lynn | Buy | 160 115 | Stock Option (right to buy) |
2024-03-21 | Levit Alex C. | Buy | 153 515 | Stock Option (right to buy) |
2024-03-21 | Lehr Martin A. | Buy | 291 402 | Stock Option (right to buy) |
2023-05-31 | Kantoff Philip W. | Buy | 25 000 | Stock Option (right to buy) |
2023-05-31 | West Linda | Buy | 25 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 72 transactions |
Buy: 4 162 098 | Sell: 2 098 089 |
Context Therapeutics Inc. Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
SGH | 0.957 |
KOPN | 0.957 |
PLAB | 0.949 |
ALR | 0.941 |
STER | 0.939 |
ELTK | 0.938 |
MRVL | 0.935 |
XBIT | 0.931 |
EVLO | 0.927 |
CALA | 0.927 |
10 Mest negative korrelasjoner | |
---|---|
OPTN | -0.919 |
SBNYP | -0.909 |
ASO | -0.901 |
FANH | -0.899 |
ATHN | -0.896 |
PHCF | -0.895 |
CDAK | -0.885 |
PAYS | -0.885 |
MTSI | -0.877 |
AGFS | -0.876 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Context Therapeutics Inc. Økonomi
Annual | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-12 044.00 (0.00 %) |
EPS: | $-1.500 |
FY | 2023 |
Omsetning: | $0 |
Bruttogevinst: | $-12 044.00 (0.00 %) |
EPS: | $-1.500 |
FY | 2022 |
Omsetning: | $0 |
Bruttogevinst: | $-9 268.00 (0.00 %) |
EPS: | $-0.900 |
FY | 2021 |
Omsetning: | $0.00 |
Bruttogevinst: | $0.00 (0.00 %) |
EPS: | $-1.024 |
Financial Reports:
No articles found.
Context Therapeutics Inc.
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also developing CLDN6xCD3 bsAb, an anti-CD3 x anti-Claudin 6 antigen bispecific monoclonal antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of an anti-claudin 6 bispecific monoclonal antibody for gynaecologic cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.